NTX1088 | First-in-class anti-PVR mAb NTX1088 - a novel oncology drug that unlocks the power of human immune system and revolutionizes cancer care
01-08-2024
-31-01-2028
Show more information
Organisation
NECTIN THERAPEUTICS LTD